nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—lung cancer	0.399	1	CbGaD
Clodronate—PTGS2—Cisplatin—lung cancer	0.0296	0.504	CbGbCtD
Clodronate—PTGS2—Etoposide—lung cancer	0.0291	0.496	CbGbCtD
Clodronate—SLC25A4—mammary gland—lung cancer	0.0101	0.0994	CbGeAlD
Clodronate—SLC25A6—respiratory system—lung cancer	0.00822	0.0813	CbGeAlD
Clodronate—SLC25A5—respiratory system—lung cancer	0.00715	0.0707	CbGeAlD
Clodronate—SLC25A6—epithelium—lung cancer	0.00687	0.0679	CbGeAlD
Clodronate—SLC25A6—bronchus—lung cancer	0.00676	0.0669	CbGeAlD
Clodronate—SLC25A5—epithelium—lung cancer	0.00597	0.0591	CbGeAlD
Clodronate—SLC25A5—bronchus—lung cancer	0.00588	0.0582	CbGeAlD
Clodronate—SLC25A5—trachea—lung cancer	0.00528	0.0523	CbGeAlD
Clodronate—SLC25A5—cardiac atrium—lung cancer	0.00496	0.0491	CbGeAlD
Clodronate—SLC25A6—bone marrow—lung cancer	0.00482	0.0476	CbGeAlD
Clodronate—SLC25A4—cardiac atrium—lung cancer	0.00465	0.046	CbGeAlD
Clodronate—SLC25A6—lung—lung cancer	0.00436	0.0432	CbGeAlD
Clodronate—SLC25A5—bone marrow—lung cancer	0.00419	0.0414	CbGeAlD
Clodronate—SLC25A6—Vinorelbine—Vinblastine—lung cancer	0.00395	0.588	CbGdCrCtD
Clodronate—SLC25A5—lung—lung cancer	0.0038	0.0375	CbGeAlD
Clodronate—SLC25A4—lung—lung cancer	0.00356	0.0352	CbGeAlD
Clodronate—SLC25A6—lymph node—lung cancer	0.00298	0.0295	CbGeAlD
Clodronate—SLC25A5—Azacitidine—Gemcitabine—lung cancer	0.00277	0.412	CbGdCrCtD
Clodronate—SLC25A5—lymph node—lung cancer	0.0026	0.0257	CbGeAlD
Clodronate—SLC25A4—lymph node—lung cancer	0.00243	0.0241	CbGeAlD
Clodronate—PTGS2—respiratory system—lung cancer	0.00135	0.0133	CbGeAlD
Clodronate—PTGS2—epithelium—lung cancer	0.00112	0.0111	CbGeAlD
Clodronate—PTGS2—bronchus—lung cancer	0.00111	0.011	CbGeAlD
Clodronate—PTGS2—trachea—lung cancer	0.000995	0.00984	CbGeAlD
Clodronate—PTGS2—bone marrow—lung cancer	0.000789	0.0078	CbGeAlD
Clodronate—PTGS2—lung—lung cancer	0.000715	0.00707	CbGeAlD
Clodronate—PTGS2—lymph node—lung cancer	0.000489	0.00483	CbGeAlD
Clodronate—Dysphagia—Paclitaxel—lung cancer	0.000356	0.00124	CcSEcCtD
Clodronate—Neoplasm malignant—Doxorubicin—lung cancer	0.000352	0.00122	CcSEcCtD
Clodronate—Infection—Topotecan—lung cancer	0.00035	0.00121	CcSEcCtD
Clodronate—Nausea—Pemetrexed—lung cancer	0.000348	0.00121	CcSEcCtD
Clodronate—Renal failure—Cisplatin—lung cancer	0.000348	0.00121	CcSEcCtD
Clodronate—Nausea—Gefitinib—lung cancer	0.000346	0.0012	CcSEcCtD
Clodronate—Infection—Erlotinib—lung cancer	0.000346	0.0012	CcSEcCtD
Clodronate—Anorexia—Vinblastine—lung cancer	0.000346	0.0012	CcSEcCtD
Clodronate—Extravasation—Doxorubicin—lung cancer	0.000344	0.00119	CcSEcCtD
Clodronate—Connective tissue disorder—Irinotecan—lung cancer	0.000344	0.00119	CcSEcCtD
Clodronate—Skin disorder—Topotecan—lung cancer	0.000342	0.00119	CcSEcCtD
Clodronate—Anaemia—Vinorelbine—lung cancer	0.000341	0.00118	CcSEcCtD
Clodronate—Skin disorder—Erlotinib—lung cancer	0.000338	0.00117	CcSEcCtD
Clodronate—Pharyngitis—Gemcitabine—lung cancer	0.000338	0.00117	CcSEcCtD
Clodronate—Angioedema—Vinorelbine—lung cancer	0.000337	0.00117	CcSEcCtD
Clodronate—Urinary tract disorder—Gemcitabine—lung cancer	0.000336	0.00117	CcSEcCtD
Clodronate—Pruritus—Teniposide—lung cancer	0.000336	0.00117	CcSEcCtD
Clodronate—Anorexia—Topotecan—lung cancer	0.000336	0.00116	CcSEcCtD
Clodronate—Connective tissue disorder—Gemcitabine—lung cancer	0.000335	0.00116	CcSEcCtD
Clodronate—Urethral disorder—Gemcitabine—lung cancer	0.000334	0.00116	CcSEcCtD
Clodronate—Anorexia—Erlotinib—lung cancer	0.000332	0.00115	CcSEcCtD
Clodronate—Hypocalcaemia—Doxorubicin—lung cancer	0.000328	0.00114	CcSEcCtD
Clodronate—Oliguria—Doxorubicin—lung cancer	0.000326	0.00113	CcSEcCtD
Clodronate—Pneumonia—Etoposide—lung cancer	0.000326	0.00113	CcSEcCtD
Clodronate—Diarrhoea—Teniposide—lung cancer	0.000325	0.00113	CcSEcCtD
Clodronate—Dehydration—Docetaxel—lung cancer	0.000325	0.00113	CcSEcCtD
Clodronate—Pneumonia—Paclitaxel—lung cancer	0.00032	0.00111	CcSEcCtD
Clodronate—Abdominal pain upper—Docetaxel—lung cancer	0.000319	0.00111	CcSEcCtD
Clodronate—Renal failure—Etoposide—lung cancer	0.000318	0.0011	CcSEcCtD
Clodronate—Creatinine increased—Doxorubicin—lung cancer	0.000316	0.00109	CcSEcCtD
Clodronate—Mediastinal disorder—Irinotecan—lung cancer	0.000315	0.00109	CcSEcCtD
Clodronate—Decreased appetite—Vinblastine—lung cancer	0.000315	0.00109	CcSEcCtD
Clodronate—Dyspnoea—Topotecan—lung cancer	0.000314	0.00109	CcSEcCtD
Clodronate—Urinary tract disorder—Cisplatin—lung cancer	0.000314	0.00109	CcSEcCtD
Clodronate—Renal failure—Paclitaxel—lung cancer	0.000312	0.00108	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.000312	0.00108	CcSEcCtD
Clodronate—Connective tissue disorder—Cisplatin—lung cancer	0.000312	0.00108	CcSEcCtD
Clodronate—Urethral disorder—Cisplatin—lung cancer	0.000311	0.00108	CcSEcCtD
Clodronate—Dyspnoea—Erlotinib—lung cancer	0.000311	0.00108	CcSEcCtD
Clodronate—Dyspepsia—Topotecan—lung cancer	0.00031	0.00108	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Docetaxel—lung cancer	0.000308	0.00107	CcSEcCtD
Clodronate—Mediastinal disorder—Gemcitabine—lung cancer	0.000307	0.00106	CcSEcCtD
Clodronate—Dyspepsia—Erlotinib—lung cancer	0.000307	0.00106	CcSEcCtD
Clodronate—Decreased appetite—Topotecan—lung cancer	0.000306	0.00106	CcSEcCtD
Clodronate—Gastrointestinal disorder—Topotecan—lung cancer	0.000304	0.00105	CcSEcCtD
Clodronate—Decreased appetite—Erlotinib—lung cancer	0.000303	0.00105	CcSEcCtD
Clodronate—Vomiting—Teniposide—lung cancer	0.000302	0.00105	CcSEcCtD
Clodronate—Dysphagia—Docetaxel—lung cancer	0.000302	0.00105	CcSEcCtD
Clodronate—Gastrointestinal disorder—Erlotinib—lung cancer	0.000301	0.00104	CcSEcCtD
Clodronate—Hepatocellular injury—Doxorubicin—lung cancer	0.0003	0.00104	CcSEcCtD
Clodronate—Rash—Teniposide—lung cancer	0.0003	0.00104	CcSEcCtD
Clodronate—Dermatitis—Teniposide—lung cancer	0.000299	0.00104	CcSEcCtD
Clodronate—Infection—Vinorelbine—lung cancer	0.000299	0.00104	CcSEcCtD
Clodronate—Bronchospasm—Docetaxel—lung cancer	0.000297	0.00103	CcSEcCtD
Clodronate—Skin disorder—Vinorelbine—lung cancer	0.000293	0.00101	CcSEcCtD
Clodronate—Urinary tract disorder—Etoposide—lung cancer	0.000287	0.000996	CcSEcCtD
Clodronate—Anorexia—Vinorelbine—lung cancer	0.000287	0.000996	CcSEcCtD
Clodronate—Abdominal pain—Vinblastine—lung cancer	0.000287	0.000994	CcSEcCtD
Clodronate—Mediastinal disorder—Cisplatin—lung cancer	0.000286	0.000993	CcSEcCtD
Clodronate—Urethral disorder—Etoposide—lung cancer	0.000285	0.000989	CcSEcCtD
Clodronate—Pharyngitis—Paclitaxel—lung cancer	0.000283	0.000982	CcSEcCtD
Clodronate—Nausea—Teniposide—lung cancer	0.000282	0.000979	CcSEcCtD
Clodronate—Urinary tract disorder—Paclitaxel—lung cancer	0.000282	0.000977	CcSEcCtD
Clodronate—Anaemia—Irinotecan—lung cancer	0.000281	0.000976	CcSEcCtD
Clodronate—Connective tissue disorder—Paclitaxel—lung cancer	0.00028	0.000972	CcSEcCtD
Clodronate—Urticaria—Topotecan—lung cancer	0.00028	0.00097	CcSEcCtD
Clodronate—Urethral disorder—Paclitaxel—lung cancer	0.00028	0.00097	CcSEcCtD
Clodronate—Abdominal pain—Topotecan—lung cancer	0.000278	0.000966	CcSEcCtD
Clodronate—Abdominal pain—Erlotinib—lung cancer	0.000275	0.000955	CcSEcCtD
Clodronate—Anaemia—Gemcitabine—lung cancer	0.000274	0.000951	CcSEcCtD
Clodronate—Renal failure acute—Methotrexate—lung cancer	0.000273	0.000946	CcSEcCtD
Clodronate—Pneumonia—Docetaxel—lung cancer	0.000271	0.000939	CcSEcCtD
Clodronate—Dyspnoea—Vinorelbine—lung cancer	0.000269	0.000932	CcSEcCtD
Clodronate—Renal failure—Docetaxel—lung cancer	0.000265	0.000918	CcSEcCtD
Clodronate—Mediastinal disorder—Etoposide—lung cancer	0.000262	0.000909	CcSEcCtD
Clodronate—Decreased appetite—Vinorelbine—lung cancer	0.000262	0.000908	CcSEcCtD
Clodronate—Gastrointestinal disorder—Vinorelbine—lung cancer	0.00026	0.000902	CcSEcCtD
Clodronate—Mediastinal disorder—Paclitaxel—lung cancer	0.000257	0.000892	CcSEcCtD
Clodronate—Anaemia—Cisplatin—lung cancer	0.000255	0.000886	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000251	0.00087	CcSEcCtD
Clodronate—Hepatic function abnormal—Doxorubicin—lung cancer	0.00025	0.000866	CcSEcCtD
Clodronate—Pruritus—Topotecan—lung cancer	0.000249	0.000864	CcSEcCtD
Clodronate—Diarrhoea—Vinblastine—lung cancer	0.000248	0.00086	CcSEcCtD
Clodronate—Infection—Irinotecan—lung cancer	0.000247	0.000856	CcSEcCtD
Clodronate—Pruritus—Erlotinib—lung cancer	0.000246	0.000855	CcSEcCtD
Clodronate—Diarrhoea—Topotecan—lung cancer	0.000241	0.000836	CcSEcCtD
Clodronate—Infection—Gemcitabine—lung cancer	0.00024	0.000834	CcSEcCtD
Clodronate—Pharyngitis—Docetaxel—lung cancer	0.00024	0.000832	CcSEcCtD
Clodronate—Urticaria—Vinorelbine—lung cancer	0.000239	0.00083	CcSEcCtD
Clodronate—Urinary tract disorder—Docetaxel—lung cancer	0.000239	0.000828	CcSEcCtD
Clodronate—Diarrhoea—Erlotinib—lung cancer	0.000238	0.000827	CcSEcCtD
Clodronate—Abdominal pain—Vinorelbine—lung cancer	0.000238	0.000826	CcSEcCtD
Clodronate—Connective tissue disorder—Docetaxel—lung cancer	0.000238	0.000824	CcSEcCtD
Clodronate—Urethral disorder—Docetaxel—lung cancer	0.000237	0.000822	CcSEcCtD
Clodronate—Anorexia—Irinotecan—lung cancer	0.000237	0.000821	CcSEcCtD
Clodronate—Renal failure acute—Doxorubicin—lung cancer	0.000236	0.000819	CcSEcCtD
Clodronate—Skin disorder—Gemcitabine—lung cancer	0.000235	0.000815	CcSEcCtD
Clodronate—Anaemia—Etoposide—lung cancer	0.000234	0.000812	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000234	0.000811	CcSEcCtD
Clodronate—Anorexia—Gemcitabine—lung cancer	0.000231	0.0008	CcSEcCtD
Clodronate—Vomiting—Vinblastine—lung cancer	0.00023	0.000799	CcSEcCtD
Clodronate—Anaemia—Paclitaxel—lung cancer	0.000229	0.000796	CcSEcCtD
Clodronate—Renal impairment—Doxorubicin—lung cancer	0.000229	0.000795	CcSEcCtD
Clodronate—Angioedema—Paclitaxel—lung cancer	0.000227	0.000787	CcSEcCtD
Clodronate—Infection—Cisplatin—lung cancer	0.000224	0.000777	CcSEcCtD
Clodronate—Vomiting—Topotecan—lung cancer	0.000224	0.000777	CcSEcCtD
Clodronate—Cardiac failure—Doxorubicin—lung cancer	0.000223	0.000775	CcSEcCtD
Clodronate—Rash—Topotecan—lung cancer	0.000222	0.00077	CcSEcCtD
Clodronate—Dermatitis—Topotecan—lung cancer	0.000222	0.000769	CcSEcCtD
Clodronate—Vomiting—Erlotinib—lung cancer	0.000222	0.000768	CcSEcCtD
Clodronate—Dyspnoea—Irinotecan—lung cancer	0.000221	0.000768	CcSEcCtD
Clodronate—Rash—Erlotinib—lung cancer	0.00022	0.000762	CcSEcCtD
Clodronate—Dermatitis—Erlotinib—lung cancer	0.000219	0.000761	CcSEcCtD
Clodronate—Skin disorder—Cisplatin—lung cancer	0.000219	0.00076	CcSEcCtD
Clodronate—Dyspepsia—Irinotecan—lung cancer	0.000219	0.000759	CcSEcCtD
Clodronate—Mediastinal disorder—Docetaxel—lung cancer	0.000218	0.000756	CcSEcCtD
Clodronate—Decreased appetite—Irinotecan—lung cancer	0.000216	0.000749	CcSEcCtD
Clodronate—Dyspnoea—Gemcitabine—lung cancer	0.000216	0.000748	CcSEcCtD
Clodronate—Nausea—Vinblastine—lung cancer	0.000215	0.000747	CcSEcCtD
Clodronate—Anorexia—Cisplatin—lung cancer	0.000215	0.000746	CcSEcCtD
Clodronate—Gastrointestinal disorder—Irinotecan—lung cancer	0.000214	0.000744	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000214	0.000743	CcSEcCtD
Clodronate—Pruritus—Vinorelbine—lung cancer	0.000213	0.000739	CcSEcCtD
Clodronate—Decreased appetite—Gemcitabine—lung cancer	0.00021	0.00073	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.00021	0.000728	CcSEcCtD
Clodronate—Nausea—Topotecan—lung cancer	0.000209	0.000726	CcSEcCtD
Clodronate—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000209	0.000725	CcSEcCtD
Clodronate—Nausea—Erlotinib—lung cancer	0.000207	0.000718	CcSEcCtD
Clodronate—Diarrhoea—Vinorelbine—lung cancer	0.000206	0.000715	CcSEcCtD
Clodronate—Infection—Etoposide—lung cancer	0.000205	0.000712	CcSEcCtD
Clodronate—Blood creatinine increased—Doxorubicin—lung cancer	0.000204	0.000709	CcSEcCtD
Clodronate—Dehydration—Doxorubicin—lung cancer	0.000203	0.000703	CcSEcCtD
Clodronate—Infection—Paclitaxel—lung cancer	0.000201	0.000698	CcSEcCtD
Clodronate—Dyspnoea—Cisplatin—lung cancer	0.000201	0.000698	CcSEcCtD
Clodronate—Skin disorder—Etoposide—lung cancer	0.000201	0.000696	CcSEcCtD
Clodronate—Abdominal pain upper—Doxorubicin—lung cancer	0.000199	0.000691	CcSEcCtD
Clodronate—Anorexia—Etoposide—lung cancer	0.000197	0.000683	CcSEcCtD
Clodronate—Skin disorder—Paclitaxel—lung cancer	0.000197	0.000683	CcSEcCtD
Clodronate—Abdominal pain—Irinotecan—lung cancer	0.000196	0.000681	CcSEcCtD
Clodronate—Decreased appetite—Cisplatin—lung cancer	0.000196	0.00068	CcSEcCtD
Clodronate—Pneumonia—Methotrexate—lung cancer	0.000195	0.000677	CcSEcCtD
Clodronate—Gastrointestinal disorder—Cisplatin—lung cancer	0.000195	0.000676	CcSEcCtD
Clodronate—Anaemia—Docetaxel—lung cancer	0.000194	0.000675	CcSEcCtD
Clodronate—Anorexia—Paclitaxel—lung cancer	0.000193	0.00067	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000192	0.000667	CcSEcCtD
Clodronate—Vomiting—Vinorelbine—lung cancer	0.000192	0.000664	CcSEcCtD
Clodronate—Renal failure—Methotrexate—lung cancer	0.000191	0.000662	CcSEcCtD
Clodronate—Rash—Vinorelbine—lung cancer	0.00019	0.000659	CcSEcCtD
Clodronate—Dermatitis—Vinorelbine—lung cancer	0.00019	0.000658	CcSEcCtD
Clodronate—Dysphagia—Doxorubicin—lung cancer	0.000188	0.000654	CcSEcCtD
Clodronate—Dyspnoea—Etoposide—lung cancer	0.000184	0.000639	CcSEcCtD
Clodronate—Dyspnoea—Paclitaxel—lung cancer	0.000181	0.000627	CcSEcCtD
Clodronate—Decreased appetite—Etoposide—lung cancer	0.00018	0.000623	CcSEcCtD
Clodronate—Nausea—Vinorelbine—lung cancer	0.000179	0.000621	CcSEcCtD
Clodronate—Gastrointestinal disorder—Etoposide—lung cancer	0.000178	0.000619	CcSEcCtD
Clodronate—Dyspepsia—Paclitaxel—lung cancer	0.000178	0.000619	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000178	0.000617	CcSEcCtD
Clodronate—Decreased appetite—Paclitaxel—lung cancer	0.000176	0.000611	CcSEcCtD
Clodronate—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000175	0.000607	CcSEcCtD
Clodronate—Pharyngitis—Methotrexate—lung cancer	0.000173	0.0006	CcSEcCtD
Clodronate—Urinary tract disorder—Methotrexate—lung cancer	0.000172	0.000597	CcSEcCtD
Clodronate—Pruritus—Gemcitabine—lung cancer	0.000171	0.000594	CcSEcCtD
Clodronate—Urethral disorder—Methotrexate—lung cancer	0.000171	0.000592	CcSEcCtD
Clodronate—Infection—Docetaxel—lung cancer	0.000171	0.000592	CcSEcCtD
Clodronate—Diarrhoea—Irinotecan—lung cancer	0.00017	0.00059	CcSEcCtD
Clodronate—Pneumonia—Doxorubicin—lung cancer	0.000169	0.000586	CcSEcCtD
Clodronate—Skin disorder—Docetaxel—lung cancer	0.000167	0.000579	CcSEcCtD
Clodronate—Diarrhoea—Gemcitabine—lung cancer	0.000166	0.000574	CcSEcCtD
Clodronate—Renal failure—Doxorubicin—lung cancer	0.000165	0.000573	CcSEcCtD
Clodronate—Urticaria—Etoposide—lung cancer	0.000164	0.000569	CcSEcCtD
Clodronate—Anorexia—Docetaxel—lung cancer	0.000164	0.000568	CcSEcCtD
Clodronate—Abdominal pain—Etoposide—lung cancer	0.000163	0.000567	CcSEcCtD
Clodronate—Urticaria—Paclitaxel—lung cancer	0.000161	0.000558	CcSEcCtD
Clodronate—Abdominal pain—Paclitaxel—lung cancer	0.00016	0.000556	CcSEcCtD
Clodronate—Vomiting—Irinotecan—lung cancer	0.000158	0.000548	CcSEcCtD
Clodronate—Mediastinal disorder—Methotrexate—lung cancer	0.000157	0.000545	CcSEcCtD
Clodronate—Rash—Irinotecan—lung cancer	0.000157	0.000543	CcSEcCtD
Clodronate—Dermatitis—Irinotecan—lung cancer	0.000156	0.000543	CcSEcCtD
Clodronate—Diarrhoea—Cisplatin—lung cancer	0.000154	0.000535	CcSEcCtD
Clodronate—Vomiting—Gemcitabine—lung cancer	0.000154	0.000534	CcSEcCtD
Clodronate—Dyspnoea—Docetaxel—lung cancer	0.000153	0.000531	CcSEcCtD
Clodronate—Rash—Gemcitabine—lung cancer	0.000153	0.000529	CcSEcCtD
Clodronate—Dermatitis—Gemcitabine—lung cancer	0.000152	0.000529	CcSEcCtD
Clodronate—Dyspepsia—Docetaxel—lung cancer	0.000151	0.000524	CcSEcCtD
Clodronate—Pharyngitis—Doxorubicin—lung cancer	0.00015	0.000519	CcSEcCtD
Clodronate—Decreased appetite—Docetaxel—lung cancer	0.000149	0.000518	CcSEcCtD
Clodronate—Urinary tract disorder—Doxorubicin—lung cancer	0.000149	0.000517	CcSEcCtD
Clodronate—Gastrointestinal disorder—Docetaxel—lung cancer	0.000148	0.000514	CcSEcCtD
Clodronate—Connective tissue disorder—Doxorubicin—lung cancer	0.000148	0.000514	CcSEcCtD
Clodronate—Urethral disorder—Doxorubicin—lung cancer	0.000148	0.000513	CcSEcCtD
Clodronate—Nausea—Irinotecan—lung cancer	0.000148	0.000512	CcSEcCtD
Clodronate—Pruritus—Etoposide—lung cancer	0.000146	0.000507	CcSEcCtD
Clodronate—Nausea—Gemcitabine—lung cancer	0.000144	0.000499	CcSEcCtD
Clodronate—Vomiting—Cisplatin—lung cancer	0.000143	0.000497	CcSEcCtD
Clodronate—Pruritus—Paclitaxel—lung cancer	0.000143	0.000497	CcSEcCtD
Clodronate—Rash—Cisplatin—lung cancer	0.000142	0.000493	CcSEcCtD
Clodronate—Dermatitis—Cisplatin—lung cancer	0.000142	0.000493	CcSEcCtD
Clodronate—Diarrhoea—Etoposide—lung cancer	0.000141	0.00049	CcSEcCtD
Clodronate—Anaemia—Methotrexate—lung cancer	0.00014	0.000486	CcSEcCtD
Clodronate—Diarrhoea—Paclitaxel—lung cancer	0.000139	0.000481	CcSEcCtD
Clodronate—Mediastinal disorder—Doxorubicin—lung cancer	0.000136	0.000472	CcSEcCtD
Clodronate—Abdominal pain—Docetaxel—lung cancer	0.000136	0.000471	CcSEcCtD
Clodronate—Nausea—Cisplatin—lung cancer	0.000134	0.000465	CcSEcCtD
Clodronate—Vomiting—Etoposide—lung cancer	0.000131	0.000456	CcSEcCtD
Clodronate—Rash—Etoposide—lung cancer	0.00013	0.000452	CcSEcCtD
Clodronate—Dermatitis—Etoposide—lung cancer	0.00013	0.000452	CcSEcCtD
Clodronate—Vomiting—Paclitaxel—lung cancer	0.000129	0.000447	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000128	0.000445	CcSEcCtD
Clodronate—Rash—Paclitaxel—lung cancer	0.000128	0.000443	CcSEcCtD
Clodronate—Dermatitis—Paclitaxel—lung cancer	0.000128	0.000443	CcSEcCtD
Clodronate—Infection—Methotrexate—lung cancer	0.000123	0.000427	CcSEcCtD
Clodronate—Nausea—Etoposide—lung cancer	0.000123	0.000426	CcSEcCtD
Clodronate—Pruritus—Docetaxel—lung cancer	0.000122	0.000421	CcSEcCtD
Clodronate—Anaemia—Doxorubicin—lung cancer	0.000121	0.000421	CcSEcCtD
Clodronate—Nausea—Paclitaxel—lung cancer	0.00012	0.000417	CcSEcCtD
Clodronate—Skin disorder—Methotrexate—lung cancer	0.00012	0.000417	CcSEcCtD
Clodronate—Anorexia—Methotrexate—lung cancer	0.000118	0.000409	CcSEcCtD
Clodronate—Diarrhoea—Docetaxel—lung cancer	0.000118	0.000408	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000111	0.000385	CcSEcCtD
Clodronate—Dyspnoea—Methotrexate—lung cancer	0.00011	0.000383	CcSEcCtD
Clodronate—Vomiting—Docetaxel—lung cancer	0.000109	0.000379	CcSEcCtD
Clodronate—Dyspepsia—Methotrexate—lung cancer	0.000109	0.000378	CcSEcCtD
Clodronate—Rash—Docetaxel—lung cancer	0.000108	0.000376	CcSEcCtD
Clodronate—Dermatitis—Docetaxel—lung cancer	0.000108	0.000375	CcSEcCtD
Clodronate—Decreased appetite—Methotrexate—lung cancer	0.000108	0.000373	CcSEcCtD
Clodronate—Gastrointestinal disorder—Methotrexate—lung cancer	0.000107	0.000371	CcSEcCtD
Clodronate—Infection—Doxorubicin—lung cancer	0.000106	0.000369	CcSEcCtD
Clodronate—Skin disorder—Doxorubicin—lung cancer	0.000104	0.000361	CcSEcCtD
Clodronate—Anorexia—Doxorubicin—lung cancer	0.000102	0.000354	CcSEcCtD
Clodronate—Nausea—Docetaxel—lung cancer	0.000102	0.000354	CcSEcCtD
Clodronate—Urticaria—Methotrexate—lung cancer	9.83e-05	0.000341	CcSEcCtD
Clodronate—Abdominal pain—Methotrexate—lung cancer	9.78e-05	0.000339	CcSEcCtD
Clodronate—Dyspnoea—Doxorubicin—lung cancer	9.56e-05	0.000331	CcSEcCtD
Clodronate—Dyspepsia—Doxorubicin—lung cancer	9.43e-05	0.000327	CcSEcCtD
Clodronate—Decreased appetite—Doxorubicin—lung cancer	9.32e-05	0.000323	CcSEcCtD
Clodronate—Gastrointestinal disorder—Doxorubicin—lung cancer	9.25e-05	0.000321	CcSEcCtD
Clodronate—Pruritus—Methotrexate—lung cancer	8.76e-05	0.000304	CcSEcCtD
Clodronate—Urticaria—Doxorubicin—lung cancer	8.51e-05	0.000295	CcSEcCtD
Clodronate—Abdominal pain—Doxorubicin—lung cancer	8.47e-05	0.000294	CcSEcCtD
Clodronate—Diarrhoea—Methotrexate—lung cancer	8.47e-05	0.000294	CcSEcCtD
Clodronate—Vomiting—Methotrexate—lung cancer	7.87e-05	0.000273	CcSEcCtD
Clodronate—Rash—Methotrexate—lung cancer	7.8e-05	0.000271	CcSEcCtD
Clodronate—Dermatitis—Methotrexate—lung cancer	7.8e-05	0.00027	CcSEcCtD
Clodronate—Pruritus—Doxorubicin—lung cancer	7.58e-05	0.000263	CcSEcCtD
Clodronate—Nausea—Methotrexate—lung cancer	7.35e-05	0.000255	CcSEcCtD
Clodronate—Diarrhoea—Doxorubicin—lung cancer	7.33e-05	0.000254	CcSEcCtD
Clodronate—SLC25A6—Metabolism—POMC—lung cancer	7.2e-05	0.000491	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—NRAS—lung cancer	7.15e-05	0.000487	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CDKN1A—lung cancer	7.15e-05	0.000487	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	7.14e-05	0.000487	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTEN—lung cancer	7.13e-05	0.000486	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MDM2—lung cancer	7.11e-05	0.000485	CbGpPWpGaD
Clodronate—SLC25A6—Disease—RAF1—lung cancer	7.08e-05	0.000483	CbGpPWpGaD
Clodronate—SLC25A4—Disease—KIT—lung cancer	7.05e-05	0.00048	CbGpPWpGaD
Clodronate—SLC25A4—Disease—APC—lung cancer	7.05e-05	0.00048	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CREBBP—lung cancer	7.01e-05	0.000478	CbGpPWpGaD
Clodronate—SLC25A6—Disease—ERBB2—lung cancer	7.01e-05	0.000478	CbGpPWpGaD
Clodronate—SLC25A4—Disease—EGF—lung cancer	6.96e-05	0.000475	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	6.92e-05	0.000472	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MTOR—lung cancer	6.92e-05	0.000472	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PIK3CB—lung cancer	6.92e-05	0.000472	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PIK3CB—lung cancer	6.91e-05	0.000471	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CD4—lung cancer	6.9e-05	0.000471	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTGS2—lung cancer	6.85e-05	0.000467	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTGS2—lung cancer	6.85e-05	0.000467	CbGpPWpGaD
Clodronate—Vomiting—Doxorubicin—lung cancer	6.81e-05	0.000236	CcSEcCtD
Clodronate—SLC25A5—Disease—EP300—lung cancer	6.8e-05	0.000464	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CXCL8—lung cancer	6.79e-05	0.000463	CbGpPWpGaD
Clodronate—Rash—Doxorubicin—lung cancer	6.76e-05	0.000234	CcSEcCtD
Clodronate—Dermatitis—Doxorubicin—lung cancer	6.75e-05	0.000234	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—MYC—lung cancer	6.66e-05	0.000454	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PIK3CD—lung cancer	6.64e-05	0.000453	CbGpPWpGaD
Clodronate—SLC25A4—Disease—BRAF—lung cancer	6.62e-05	0.000452	CbGpPWpGaD
Clodronate—SLC25A5—Disease—SRC—lung cancer	6.61e-05	0.000451	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ALB—lung cancer	6.56e-05	0.000447	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6R—lung cancer	6.54e-05	0.000446	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CREBBP—lung cancer	6.53e-05	0.000445	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ATP5H—lung cancer	6.51e-05	0.000444	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CASP3—lung cancer	6.5e-05	0.000443	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL2—lung cancer	6.49e-05	0.000442	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—APOA1—lung cancer	6.46e-05	0.000441	CbGpPWpGaD
Clodronate—SLC25A5—Disease—STAT3—lung cancer	6.38e-05	0.000435	CbGpPWpGaD
Clodronate—Nausea—Doxorubicin—lung cancer	6.37e-05	0.000221	CcSEcCtD
Clodronate—SLC25A5—Disease—NRAS—lung cancer	6.36e-05	0.000434	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CCND1—lung cancer	6.33e-05	0.000431	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—APC—lung cancer	6.27e-05	0.000428	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MAP2K1—lung cancer	6.24e-05	0.000425	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	6.2e-05	0.000423	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3CD—lung cancer	6.19e-05	0.000422	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—KRAS—lung cancer	6.15e-05	0.00042	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MMP9—lung cancer	6.14e-05	0.000419	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MAPK3—lung cancer	6.09e-05	0.000415	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CDKN1A—lung cancer	5.99e-05	0.000408	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	5.99e-05	0.000408	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTEN—lung cancer	5.98e-05	0.000407	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTEN—lung cancer	5.97e-05	0.000407	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MYC—lung cancer	5.93e-05	0.000404	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CG—lung cancer	5.9e-05	0.000402	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	5.84e-05	0.000398	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	5.82e-05	0.000397	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PLBD1—lung cancer	5.81e-05	0.000396	CbGpPWpGaD
Clodronate—SLC25A5—Disease—EGFR—lung cancer	5.8e-05	0.000395	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PIK3CB—lung cancer	5.79e-05	0.000395	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS2—lung cancer	5.74e-05	0.000391	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	5.71e-05	0.000389	CbGpPWpGaD
Clodronate—SLC25A6—Disease—EP300—lung cancer	5.7e-05	0.000389	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—EP300—lung cancer	5.7e-05	0.000388	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—POMC—lung cancer	5.62e-05	0.000383	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	5.55e-05	0.000378	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MDM2—lung cancer	5.55e-05	0.000378	CbGpPWpGaD
Clodronate—SLC25A6—Disease—SRC—lung cancer	5.54e-05	0.000378	CbGpPWpGaD
Clodronate—SLC25A4—Disease—RAF1—lung cancer	5.53e-05	0.000377	CbGpPWpGaD
Clodronate—SLC25A5—Disease—KRAS—lung cancer	5.48e-05	0.000373	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CREBBP—lung cancer	5.47e-05	0.000373	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ERBB2—lung cancer	5.47e-05	0.000373	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3CB—lung cancer	5.4e-05	0.000368	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MTOR—lung cancer	5.4e-05	0.000368	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CD4—lung cancer	5.39e-05	0.000367	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTGS2—lung cancer	5.35e-05	0.000365	CbGpPWpGaD
Clodronate—SLC25A6—Disease—STAT3—lung cancer	5.34e-05	0.000364	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NRAS—lung cancer	5.33e-05	0.000363	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HSD17B10—lung cancer	5.31e-05	0.000362	CbGpPWpGaD
Clodronate—PTGS2—Disease—PGAM1—lung cancer	5.25e-05	0.000358	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—HRAS—lung cancer	5.23e-05	0.000357	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MAPK3—lung cancer	5.22e-05	0.000356	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CD—lung cancer	5.19e-05	0.000354	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ALB—lung cancer	5.12e-05	0.000349	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MAPK3—lung cancer	5.11e-05	0.000348	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MYC—lung cancer	5.07e-05	0.000346	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PIK3CA—lung cancer	5.03e-05	0.000343	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTEN—lung cancer	5e-05	0.000341	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MYC—lung cancer	4.97e-05	0.000339	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—EGFR—lung cancer	4.96e-05	0.000338	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	4.94e-05	0.000337	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CKB—lung cancer	4.94e-05	0.000337	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	4.92e-05	0.000336	CbGpPWpGaD
Clodronate—PTGS2—Disease—SDC4—lung cancer	4.9e-05	0.000334	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	4.87e-05	0.000332	CbGpPWpGaD
Clodronate—SLC25A6—Disease—EGFR—lung cancer	4.86e-05	0.000331	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL6—lung cancer	4.82e-05	0.000329	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—EP300—lung cancer	4.77e-05	0.000325	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CDKN1A—lung cancer	4.68e-05	0.000319	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTEN—lung cancer	4.67e-05	0.000318	CbGpPWpGaD
Clodronate—SLC25A5—Disease—HRAS—lung cancer	4.65e-05	0.000317	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CNDP2—lung cancer	4.64e-05	0.000316	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTM2—lung cancer	4.64e-05	0.000316	CbGpPWpGaD
Clodronate—SLC25A6—Disease—KRAS—lung cancer	4.59e-05	0.000313	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CB—lung cancer	4.52e-05	0.000308	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTMR3—lung cancer	4.52e-05	0.000308	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS2—lung cancer	4.48e-05	0.000305	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6—lung cancer	4.46e-05	0.000304	CbGpPWpGaD
Clodronate—SLC25A4—Disease—EP300—lung cancer	4.45e-05	0.000303	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	4.42e-05	0.000301	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PGAM1—lung cancer	4.4e-05	0.0003	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SRC—lung cancer	4.33e-05	0.000295	CbGpPWpGaD
Clodronate—PTGS2—Disease—SKI—lung cancer	4.33e-05	0.000295	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	4.3e-05	0.000293	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	4.29e-05	0.000293	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PIK3CA—lung cancer	4.22e-05	0.000287	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PIK3CA—lung cancer	4.21e-05	0.000287	CbGpPWpGaD
Clodronate—PTGS2—Disease—B4GALT5—lung cancer	4.2e-05	0.000286	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP2A7—lung cancer	4.2e-05	0.000286	CbGpPWpGaD
Clodronate—SLC25A4—Disease—STAT3—lung cancer	4.17e-05	0.000284	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TP53—lung cancer	4.17e-05	0.000284	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	4.16e-05	0.000284	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NRAS—lung cancer	4.16e-05	0.000284	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	4.15e-05	0.000283	CbGpPWpGaD
Clodronate—SLC25A5—Disease—AKT1—lung cancer	4.11e-05	0.00028	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SDC4—lung cancer	4.11e-05	0.00028	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MAPK3—lung cancer	3.99e-05	0.000272	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	3.96e-05	0.00027	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTEN—lung cancer	3.91e-05	0.000266	CbGpPWpGaD
Clodronate—SLC25A6—Disease—HRAS—lung cancer	3.9e-05	0.000266	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MYC—lung cancer	3.88e-05	0.000264	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	3.85e-05	0.000263	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL6—lung cancer	3.81e-05	0.00026	CbGpPWpGaD
Clodronate—SLC25A4—Disease—EGFR—lung cancer	3.79e-05	0.000259	CbGpPWpGaD
Clodronate—PTGS2—Disease—PXN—lung cancer	3.76e-05	0.000256	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	3.75e-05	0.000256	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—RRM1—lung cancer	3.74e-05	0.000255	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTA3—lung cancer	3.74e-05	0.000255	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6—lung cancer	3.73e-05	0.000255	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—EP300—lung cancer	3.73e-05	0.000254	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKR1C1—lung cancer	3.68e-05	0.000251	CbGpPWpGaD
Clodronate—SLC25A4—Disease—KRAS—lung cancer	3.58e-05	0.000244	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	3.55e-05	0.000242	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PIK3CA—lung cancer	3.53e-05	0.000241	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—B4GALT5—lung cancer	3.52e-05	0.00024	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	3.45e-05	0.000235	CbGpPWpGaD
Clodronate—SLC25A6—Disease—AKT1—lung cancer	3.44e-05	0.000235	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—AKT1—lung cancer	3.44e-05	0.000235	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTA4—lung cancer	3.42e-05	0.000233	CbGpPWpGaD
Clodronate—PTGS2—Disease—NPPA—lung cancer	3.39e-05	0.000231	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	3.38e-05	0.00023	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.34e-05	0.000228	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTA2—lung cancer	3.33e-05	0.000227	CbGpPWpGaD
Clodronate—PTGS2—Disease—PPIA—lung cancer	3.3e-05	0.000225	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3CA—lung cancer	3.29e-05	0.000224	CbGpPWpGaD
Clodronate—PTGS2—Disease—ALDOA—lung cancer	3.28e-05	0.000224	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTA1—lung cancer	3.22e-05	0.000219	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	3.19e-05	0.000217	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCC3—lung cancer	3.18e-05	0.000217	CbGpPWpGaD
Clodronate—PTGS2—Disease—ADCY1—lung cancer	3.1e-05	0.000211	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AKR1C1—lung cancer	3.08e-05	0.00021	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HRAS—lung cancer	3.05e-05	0.000208	CbGpPWpGaD
Clodronate—PTGS2—Disease—ENO2—lung cancer	3.04e-05	0.000207	CbGpPWpGaD
Clodronate—PTGS2—Disease—PPP2R1B—lung cancer	3.02e-05	0.000206	CbGpPWpGaD
Clodronate—PTGS2—Disease—SMARCA4—lung cancer	3.02e-05	0.000206	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—UGT1A1—lung cancer	2.99e-05	0.000204	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	2.93e-05	0.0002	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6—lung cancer	2.91e-05	0.000199	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—AKT1—lung cancer	2.88e-05	0.000197	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GNG11—lung cancer	2.88e-05	0.000197	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.87e-05	0.000196	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	2.83e-05	0.000193	CbGpPWpGaD
Clodronate—PTGS2—Disease—ENO1—lung cancer	2.76e-05	0.000188	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CA—lung cancer	2.76e-05	0.000188	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALDOA—lung cancer	2.75e-05	0.000187	CbGpPWpGaD
Clodronate—SLC25A4—Disease—AKT1—lung cancer	2.69e-05	0.000183	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NCOA3—lung cancer	2.67e-05	0.000182	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.62e-05	0.000179	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ADCY1—lung cancer	2.59e-05	0.000177	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCG2—lung cancer	2.59e-05	0.000177	CbGpPWpGaD
Clodronate—PTGS2—Disease—APP—lung cancer	2.57e-05	0.000175	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGF9—lung cancer	2.54e-05	0.000173	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HPGDS—lung cancer	2.54e-05	0.000173	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ENO2—lung cancer	2.54e-05	0.000173	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPP2R1B—lung cancer	2.53e-05	0.000172	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.49e-05	0.00017	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTT1—lung cancer	2.47e-05	0.000168	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GCLC—lung cancer	2.44e-05	0.000166	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP2A6—lung cancer	2.44e-05	0.000166	CbGpPWpGaD
Clodronate—PTGS2—Disease—JUNB—lung cancer	2.43e-05	0.000166	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.43e-05	0.000166	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.39e-05	0.000163	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ENO1—lung cancer	2.31e-05	0.000158	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.3e-05	0.000157	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.27e-05	0.000155	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—AKT1—lung cancer	2.25e-05	0.000154	CbGpPWpGaD
Clodronate—PTGS2—Disease—FOXO3—lung cancer	2.13e-05	0.000145	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP2E1—lung cancer	2.07e-05	0.000141	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NQO1—lung cancer	2.05e-05	0.00014	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.01e-05	0.000137	CbGpPWpGaD
Clodronate—PTGS2—Disease—HES1—lung cancer	1.89e-05	0.000129	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—STK11—lung cancer	1.85e-05	0.000126	CbGpPWpGaD
Clodronate—PTGS2—Disease—ERCC2—lung cancer	1.76e-05	0.00012	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.73e-05	0.000118	CbGpPWpGaD
Clodronate—PTGS2—Disease—ERBB3—lung cancer	1.73e-05	0.000118	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTP1—lung cancer	1.71e-05	0.000117	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CAT—lung cancer	1.66e-05	0.000113	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.65e-05	0.000113	CbGpPWpGaD
Clodronate—PTGS2—Disease—TERT—lung cancer	1.65e-05	0.000113	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCB1—lung cancer	1.62e-05	0.00011	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGFR1—lung cancer	1.61e-05	0.000109	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TYMS—lung cancer	1.59e-05	0.000108	CbGpPWpGaD
Clodronate—PTGS2—Disease—HIF1A—lung cancer	1.58e-05	0.000108	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTM1—lung cancer	1.57e-05	0.000107	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOA1—lung cancer	1.53e-05	0.000104	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP1A1—lung cancer	1.49e-05	0.000102	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ERCC2—lung cancer	1.48e-05	0.000101	CbGpPWpGaD
Clodronate—PTGS2—Disease—APC—lung cancer	1.39e-05	9.5e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—KIT—lung cancer	1.39e-05	9.5e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—EGF—lung cancer	1.38e-05	9.39e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—BRAF—lung cancer	1.31e-05	8.93e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6R—lung cancer	1.29e-05	8.82e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CREBBP—lung cancer	1.29e-05	8.81e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOA1—lung cancer	1.28e-05	8.71e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MAP2K1—lung cancer	1.23e-05	8.4e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CD—lung cancer	1.22e-05	8.35e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.22e-05	8.34e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CG—lung cancer	1.17e-05	7.95e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—POMC—lung cancer	1.11e-05	7.57e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MDM2—lung cancer	1.1e-05	7.48e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—RAF1—lung cancer	1.09e-05	7.45e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CREBBP—lung cancer	1.08e-05	7.37e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—ERBB2—lung cancer	1.08e-05	7.37e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTOR—lung cancer	1.07e-05	7.28e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CB—lung cancer	1.07e-05	7.28e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CD4—lung cancer	1.07e-05	7.26e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CD—lung cancer	1.03e-05	6.99e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALB—lung cancer	1.01e-05	6.9e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CDKN1A—lung cancer	9.24e-06	6.3e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PTEN—lung cancer	9.22e-06	6.29e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CB—lung cancer	8.94e-06	6.09e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—EP300—lung cancer	8.8e-06	6e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SRC—lung cancer	8.55e-06	5.83e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—STAT3—lung cancer	8.25e-06	5.62e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NRAS—lung cancer	8.23e-06	5.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MAPK3—lung cancer	7.88e-06	5.37e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PTEN—lung cancer	7.72e-06	5.27e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MYC—lung cancer	7.67e-06	5.23e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—EGFR—lung cancer	7.5e-06	5.11e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—EP300—lung cancer	7.37e-06	5.02e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—KRAS—lung cancer	7.08e-06	4.83e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CA—lung cancer	6.51e-06	4.44e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HRAS—lung cancer	6.02e-06	4.1e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6—lung cancer	5.76e-06	3.93e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CA—lung cancer	5.45e-06	3.72e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT1—lung cancer	5.32e-06	3.62e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AKT1—lung cancer	4.45e-06	3.04e-05	CbGpPWpGaD
